Synthetic Biologics Inc logo

Synthetic Biologics Inc

$ 1.04 -0.02 (-1.89%) 10:08 PM EST
P/E:
At Loss
P/B:
0.26
Market Cap:
$ 16.48M
Enterprise V:
$ -33.77M
Volume:
40.15K
Avg Vol (2M):
210.79K
Also Trade In:
Volume:
40.15K
Market Cap $:
16.48M
PE Ratio:
At Loss
Avg Vol (2-Month):
210.79K
Enterprise Value $:
-33.77M
PB Ratio:
0.26
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery stage biotherapeutics for the treatment of phenylketonuria.
Name Current Vs Industry Vs History
Cash-To-Debt 30.78
Equity-to-Asset 0.75
Debt-to-Equity 0.03
Debt-to-EBITDA -0.1
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0.41
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 3.49
9-Day RSI 10.39
14-Day RSI 18.69
6-1 Month Momentum % -56.93
12-1 Month Momentum % -69.26

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.14
Quick Ratio 4.14
Cash Ratio 3.94

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -104.3
Name Current Vs Industry Vs History
ROE % -25.77
ROA % -22.56
ROIC % -108.84
ROC (Joel Greenblatt) % -1133.3
ROCE % -24.62

Financials (Next Earnings Date:2022-11-03 Est.)

SYN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with AMEX:SYN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.21
Beta 0.89
Volatility % 42.86
14-Day RSI 18.69
14-Day ATR ($) 0.088352
20-Day SMA ($) 1.3365
12-1 Month Momentum % -69.26
52-Week Range ($) 1.03 - 4.95
Shares Outstanding (Mil) 15.84

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Synthetic Biologics Inc Filings

Document Form Filing Date
No Filing Data

Synthetic Biologics Inc Analysis

Share your research

Headlines

See More
No news.